Rearrangements of the intermediate filament GFAP in primary human schwannoma cells

Tamara Utermark; Simone J.A. Schubert; C. Oliver Hanemann

doi:10.1016/j.nbd.2004.11.015

Rearrangements of the intermediate filament GFAP in primary human schwannoma cells

Tamara Utermark
, Simone J.A. Schubert
, C. Oliver Hanemann^*

^*Corresponding author for this work

Peninsula Medical School

Ulm University

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-9
Number of pages	0
Journal	Neurobiology of Disease
Volume	19
Issue number	0
DOIs	https://doi.org/10.1016/j.nbd.2004.11.015
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

tumor suppressor merlin
intermediate filament
perinuclear collapse
Rac activation
tyrosine phosphorylation

Access to Document

10.1016/j.nbd.2004.11.015

Cite this

@article{3628d48b876b47eeb680c7363e093e32,

title = "Rearrangements of the intermediate filament GFAP in primary human schwannoma cells",

keywords = "tumor suppressor merlin, intermediate filament, perinuclear collapse, Rac activation, tyrosine phosphorylation",

author = "Tamara Utermark and Schubert, \{Simone J.A.\} and Hanemann, \{C. Oliver\}",

year = "2005",

doi = "10.1016/j.nbd.2004.11.015",

language = "English",

volume = "19",

pages = "1--9",

journal = "Neurobiology of Disease",

issn = "0969-9961",

publisher = "Academic Press Inc.",

number = "0",

}

TY - JOUR

T1 - Rearrangements of the intermediate filament GFAP in primary human schwannoma cells

AU - Utermark, Tamara

AU - Schubert, Simone J.A.

AU - Hanemann, C. Oliver

PY - 2005

Y1 - 2005

KW - tumor suppressor merlin

KW - intermediate filament

KW - perinuclear collapse

KW - Rac activation

KW - tyrosine phosphorylation

U2 - 10.1016/j.nbd.2004.11.015

DO - 10.1016/j.nbd.2004.11.015

M3 - Article

SN - 0969-9961

VL - 19

SP - 1

EP - 9

JO - Neurobiology of Disease

JF - Neurobiology of Disease

IS - 0

ER -